Printer Friendly
The Free Library
4,659,529 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A look at incoming Eli Lilly CEO John Lechleiter


NAME — John Lechleiter

AGE — 54

EXPERIENCE — Served as president and chief operating officer of Eli Lilly and Co. since October 2005. Also served as vice president of pharmaceutical products and corporate development. Started at Lilly in 1979 as a senior organic chemist.

EDUCATION — Bachelor of science degree in chemistry from Xavier University, master's and doctorate from Harvard University.

FAMILY — Wife Sarah; three grown children, Dan, Andrew and Elizabeth.

OUTSIDE LILLY — Avid golfer with handicap in the high 20s, serves on Xavier University Board of Trustees, attends St. John the Evangelist Catholic Church, helped found Providence Cristo Rey High School, recently switched to decaffeinated coffee.

Copyright 2008 AP Features
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright (c) Mochila, Inc.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Author:The Associated Press
Publication:AP Features
Date:Mar 30, 2008
Words:110
Previous Article:Federal agencies saying their rules pre-empt injury suits
Next Article:Highly charged, often lurid, inquest into deaths of Princess Diana and her lover nears its end



Related Articles
Lilly reports lower 4Q profit; adjusted results beat expectations
1-time charges crimp Lilly's 4Q earnings
Eli Lilly 2Q profit slips on research and development charges, but raises outlook
Lilly profits rise on strong sales of Cymbalta; financial outlook gets a boost
Taurel to step down as CEO of Eli Lilly on March 31, Lechleiter named successor
Taurel to retire as Eli Lilly CEO
Taurel stepping down as Lilly CEO, being replaced by Lechleiter
Eli Lilly reports better-than-expected 4th-quarter results
Lilly's Taurel sees total compensation rise 18 percent in 2007
Big pension fund CalPERS to withold votes for 3 Eli Lilly directors, cites stock's performance

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles